Summary of earlier studiesReview · Pharmaceuticals (Basel, Switzerland) · Sep 26, 2026

Review maps studies of thymosin alpha 1 as an add-on treatment for cancer

This review summarized 26 studies, mostly from China, using a drug called thymosin alpha 1 with cancer care. It does not show whether the drug works or is safe.

Study · Journal of traditional and complementary medicine · Sep 5, 2026

A prospective clinical study on the effectiveness of Phellinus igniarius decoction in treating immune dysfunction in colorectal cancer patients following…

BACKGROUND AND AIM: Chemotherapy for colorectal cancer (CRC) frequently induces immune dysfunction, which can negatively affect patient prognosis.

Study · Advanced science (Weinheim, Baden-Wurttemberg, Germany) · Sep 4, 2026

Immune peptide Thymosin alpha-1 protects brain cells in stroke studies in mice

Scientists found a thymus peptide may shield brain cells from dying after stroke. This is a lab and animal finding, so it does not show the same effect in people.